The Section for Translational Surgical Oncology and Biomaterial Banks at the University of Lübeck conducts research focusing on the role of genomic instability in the development and progression of solid tumors. Investigations also center on identifying and characterizing proteins, autoantibodies, CTCs (circulating tumor cells), platelets, and other blood or body fluids.
The primary focus of the group is oncological research, leveraging protein biomarkers for diagnosis, prognosis, therapy, and aftercare. To this end, the research group of Prof. Gemoll and colleagues have established complex methods such as ESI- & MALDI-MS, 2-DIGE, MALDI imaging, and quantitative Western blotting within the clinical setting. These methods have yielded valuable results through close collaboration with clinics and institutes.
Complex protein analysis of large data sets with up to 10,000 proteins in up to 150 samples
Partners in research collaborations find it challenging to deal with the complexity of data provided
The time required for analyses can be long
Significant time savings in analysis
Reduction of data complexity
Easier sharing of data sets
